Fujisawa, Japan

Kunio Isshika

This inventor holds 1 USPTO granted patent. Top assignee: Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunio Isshika: Innovator in Physiologically Active Compounds

Introduction

Kunio Isshika is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds with physiological activity. His work focuses on creating innovative solutions that have the potential to impact health and medicine.

Latest Patents

Isshika holds a patent for "Physiologically active erbstatin analogue compounds and compositions." This invention provides new physiological active substance erbstatin analogue compounds of a general formula (I). These compounds exhibit excellent tyrosine-specific protein-kinase inhibitory activity, antitumor activity, and antimicrobial activity. The specific structure includes variations where R.sup.1 can represent a hydrogen atom, a lower alkanoyl group, or a lower alkyl group, with 'n' being a positive integer ranging from 1 to 3. This patent highlights his innovative approach to addressing critical health challenges.

Career Highlights

Throughout his career, Kunio Isshika has been associated with Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai, where he has contributed to various research initiatives. His dedication to advancing scientific knowledge has positioned him as a key figure in his field.

Collaborations

Isshika has worked alongside esteemed colleagues such as Kuniaki Tatsuta and Tomio Takeuchi. Their collaborative efforts have further enhanced the research and development of innovative compounds.

Conclusion

Kunio Isshika's work in developing physiologically active compounds showcases his commitment to innovation in biochemistry. His contributions have the potential to lead to significant advancements in medical science and therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…